PEN

Penumbra

Stock NYSE – Stock Market Prices, News & Analysis

A company specialized in the design, development, and marketing of medical devices for neurology and neurosurgery.

$ 330.86
1.87 %

Penumbra

$ 330.86
1.87 %
PEN

A company specialized in the design, development, and marketing of medical devices for neurology and neurosurgery.

Price history of Penumbra
Price history of Penumbra

Performance & Momentum

6 Months 28.77 %
1 Year 24.92 %
3 Years 20.05 %
5 Years 20.99 %

Strategic Analysis

Penumbra • 2026

Penumbra Inc positions itself as a specialized player in neurosurgical medical devices, leveraging targeted innovations to address critical needs in neurology. Its model is based on the development of high-value technological solutions, granting it a strong niche in the American healthcare market.

Strengths
  • In-depth expertise in neurovascular medical devices
  • Regular growth supported by product innovations
  • Presence in a segment with high entry barriers and potential for increasing demand
Weaknesses
  • Significant dependence on the North American market
  • Exposure to regulatory constraints specific to the medical sector
Momentum

The positive momentum reflects a favorable business dynamic fueled by strong medium-term performance. Without any major recent news, the context suggests a consolidation while maintaining an attractive profile for investors focused on technological growth in healthcare.

Analysis performed 1 month ago

Similar stocks to Penumbra

Was this page helpful?

Your feedback helps us improve our research.

Take control
of your investments

Track your portfolios, analyze your performance and receive personalized insights to invest with strategy.

  • Real-time multi-portfolio tracking
  • AI analysis of your positions
  • Counter your cognitive biases
Anantys Invest on iPhone